ask="18.85"
ask_size="300"
average_daily_volume="215022"
bid="18.18"
bid_size="200"
book_value="3.21"
change="+0.90"
change_from_200_day_moving_average="7.62"
change_from_50_day_moving_average="4.19"
change_from_52_week_high="-2.71"
change_From_52_week_low="14.21"
change_in_percent="+5.01%"
close="18.85"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.48"
ebitda="-21.87M"
eps_estimate_current_year="-2.61"
eps_estimate_next_quarter="-0.71"
eps_estimate_next_year="-2.64"
ex_dividend_date="N/A"
float_shares="6537000"
high="19.94"
high_52_weeks="21.56"
last_trade_date="1/4/2017"
last_trade_price="18.85"
last_trade_size="1623"
last_trade_time="4:00pm"
low="18.02"
low_52_weeks="4.64"
market_capitalization="187.61M"
moving_average_200_day="11.23"
moving_average_50_day="14.66"
name="Zynerba Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="30.43"
open="18.09"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+67.79%"
percent_change_from_50_day_moving_average="+28.57%"
percent_change_from_52_week_high="-12.58%"
percent_change_from_52_week_low="+306.25%"
previous_close="17.95"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="5.60"
price_per_sales="3160.72"
revenue="56524.00"
shares_outstanding="9953000"
short_ratio="6.60"
stock_exchange="NGM"
symbol="ZYNE"
volume="578544"
weeks_range_52="4.64 - 21.56"
